Indefinite Delivery Contract SPE2DB24D9223

This indefinite delivery contract (IDC) was awarded by the U.S. Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide.

Through this single-award IDC under the DLA's SPE2DB program, DMS Pharmaceutical Group has been awarded numerous delivery orders to supply a diverse array of pharmaceuticals, such as flumazenil injections, prednisone tablets, epinephrine auto-injectors, oncology drugs like Keytruda and Kadcyla, and specialty medications like Nucala and Xolair. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct awards for the DLA's pharmaceutical Prime Vendor programs supporting the Department of Defense and Department of Veterans Affairs medical facilities globally.